Earlier studies suggested that pharmacological antagonism of the ligand–RAGE axis, using soluble RAGE, or genetic modifications such as global deletion of Ager (the gene encoding RAGE), attenuated acceleration of atherosclerosis progression in diabetic mice [51,52,53]. The gene discussed is AGER; the disease is atherosclerosis.